Keep Me Logged In
Vertex surged more than 40 percent on promising results of its cystic fibrosis treatment. Robyn Karnauskas, Deutsche Bank, is not selling the stock on the move and sees more upside ahead.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by